The medications slow digestion, regulate energy use and balance, and suppress appetite
Additionally, these medications act on central appetite regulation centers in the hypothalamus, contributing to reduced caloric intake
What's your protocol if new safety concerns emerge about compounded formulations
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) represent one of the most transformative pharmacologic developments in metabolic medicine
Yes, Semaglutide can make you tired, though it is typically a temporary side effect that occurs as your body adjusts to the medication
Moreover, the FDA has issued a warning letter for consumers stating that these illegally marketed drugs may be counterfeit, may contain harmful ingredients, and may contain too much, too little, or no active ingredients of the medication at all